BMI1 also possesses functions independent of CDKN2A repression, including the regulation of genes involved in differentiation and cell contact inhibition in Ewing sarcoma and androgen receptor expression in prostate cancer [28, 51]. This evidence concerns the gene CDKN2A and prostate carcinoma.